46,XY complete gonadal dysgenesis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:242OMIM:154230Q99.1
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

46,XY complete gonadal dysgenesis, also known as Swyer syndrome or 46,XY pure gonadal dysgenesis, is a rare disorder of sex development in which individuals have a 46,XY karyotype (typically associated with male development) but develop as phenotypically female due to complete failure of testicular development during embryonic life. The gonads remain as non-functional fibrous tissue called streak gonads, which do not produce testosterone or anti-Müllerian hormone. As a result, the internal reproductive structures develop along the female pathway, with a uterus and fallopian tubes present, and the external genitalia appear typically female. Affected individuals are usually raised as girls and come to medical attention during adolescence when they fail to undergo spontaneous puberty and present with primary amenorrhea (absence of menstruation). They are typically of normal or tall female stature, as the Y chromosome's growth-promoting effects are partially retained. The streak gonads carry a significant risk (estimated 15–35%) of developing gonadal tumors, particularly gonadoblastoma and dysgerminoma, which necessitates prophylactic gonadectomy (surgical removal of the streak gonads) once the diagnosis is made. The condition can be caused by mutations in several genes, most notably SRY (the sex-determining region on the Y chromosome), but also NR5A1 (SF1), DHH, MAP3K1, and others. In many cases, the underlying genetic cause remains unidentified. Treatment involves hormone replacement therapy with estrogen and progesterone to induce puberty and maintain secondary sexual characteristics and bone health. Fertility is not possible through natural conception, but pregnancy via donor oocytes and in vitro fertilization has been achieved in some individuals, as the uterus is present and functional when hormonally supported.

Also known as:

Clinical phenotype terms— hover any for plain English:

Male pseudohermaphroditismHP:0000037Dysplastic testisHP:0008733
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Juvenile

Begins in the teen years

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 46,XY complete gonadal dysgenesis.

View clinical trials →

No actively recruiting trials found for 46,XY complete gonadal dysgenesis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 46,XY complete gonadal dysgenesis community →

Specialists

1 foundView all specialists →
VM
Veronica Gomez-Lobo, M.D.
WASHINGTON, DC
Specialist
PI on 6 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 46,XY complete gonadal dysgenesis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 46,XY complete gonadal dysgenesisForum →

No community posts yet. Be the first to share your experience with 46,XY complete gonadal dysgenesis.

Start the conversation →

Latest news about 46,XY complete gonadal dysgenesis

No recent news articles for 46,XY complete gonadal dysgenesis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about 46,XY complete gonadal dysgenesis

What is 46,XY complete gonadal dysgenesis?

46,XY complete gonadal dysgenesis, also known as Swyer syndrome or 46,XY pure gonadal dysgenesis, is a rare disorder of sex development in which individuals have a 46,XY karyotype (typically associated with male development) but develop as phenotypically female due to complete failure of testicular development during embryonic life. The gonads remain as non-functional fibrous tissue called streak gonads, which do not produce testosterone or anti-Müllerian hormone. As a result, the internal reproductive structures develop along the female pathway, with a uterus and fallopian tubes present, and

At what age does 46,XY complete gonadal dysgenesis typically begin?

Typical onset of 46,XY complete gonadal dysgenesis is juvenile. Age of onset can vary across affected individuals.

Which specialists treat 46,XY complete gonadal dysgenesis?

1 specialists and care centers treating 46,XY complete gonadal dysgenesis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.